SCANDINAVIAN BIOPHARMA HOLDING AB has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are SERUM INST OF INDIA PVT LTD, VAXIMM AG and FUNDACAO BUTANTAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 2 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Hong Kong | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Climate change adaptation technologies | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Carlin Nils | 14 |
#2 | Tobias Joshua | 14 |
#3 | Svennerholm Ann-Mari | 13 |
#4 | Holmgren Jan | 4 |
#5 | Ann-Mari Svennerholm | 2 |
#6 | Nils Carlin | 2 |
#7 | Joshua Tobias | 2 |
#8 | Svennerholm Ann Mari | 1 |
#9 | Jan Holmgren | 1 |
Publication | Filing date | Title |
---|---|---|
CA2846279A1 | Method for increasing etec cs6 antigen presentation on cell surface and products obtainable thereof | |
AU2011376755A1 | Vaccine for protection against ETEC induced diarrhea comprising dmLT. |